Showing results (2221-2230 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|July 15, 2021
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort studyMaria Sund, Miguel Garcia-Argibay, Hans Garmo, et al.Breast (Edinburgh, Scotland)|July 16, 2021
Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trialsHong-Fei Gao, Ying-Yi Lin, Teng Zhu, et al.Breast (Edinburgh, Scotland)|July 16, 2021
Breast-related and body-related quality of life following autologous breast reconstruction is superior to implant-based breast reconstruction - A long-term follow-up studyRenée Ml Miseré, Sander Mj van Kuijk, Eva L Claassens, et al.Breast (Edinburgh, Scotland)|July 18, 2021
Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survivalAbdulla Al-Rashdan, Yuan Xu, May Lynn Quan, et al.Breast (Edinburgh, Scotland)|July 5, 2021
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise studyEija Roine, Harri Sintonen, Pirkko-Liisa Kellokumpu-Lehtinen, et al.Breast (Edinburgh, Scotland)|December 3, 2020
Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) networkAnne-Sophie Boudy, Clément Ferrier, Lise Selleret, et al.Breast (Edinburgh, Scotland)|December 7, 2020
Clinicopathological features of breast cancer without mammographic findings suggesting malignancyMei Nakamura, Yumiko Ishizuka, Yoshiya Horimoto, et al.Breast (Edinburgh, Scotland)|December 7, 2020
A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of ScotlandLaszlo Romics, Julie Doughty, Sheila Stallard, et al.Breast (Edinburgh, Scotland)|December 21, 2020
Mammographic sensitivity as a function of tumor size: A novel estimation based on population-based screening dataJing Wang, Pam Gottschal, Lilu Ding, et al.Breast (Edinburgh, Scotland)|December 22, 2020
CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancerSerena Di Cosimo, Luca Porcu, Fatima CardosoPageof 367